Qinglei Zuo
Corporate Officer/Principal chez OCUMENSION THERAPEUTICS
Profil
Qinglei Zuo is the Chief Commercial Officer at Ocumension Therapeutics since 2021.
Prior to this, he worked as the Head of Sales and Director of Business Development at Santen Pharmaceutical (China) Co. Ltd.
from 2015 to 2018, Manager of Product and District Sales at Eisai China, Inc. from 2010 to 2015, and Project Manager of the Research and Development Department at Shanghai Hengrui Pharmaceutical Co., Ltd.
from 2009 to 2010.
He graduated from Shanghai Institute of Pharmaceutical Industry in 2009 with a graduate degree and from Yantai University in 2006 with an undergraduate degree.
Postes actifs de Qinglei Zuo
| Sociétés | Poste | Début |
|---|---|---|
| OCUMENSION THERAPEUTICS | Corporate Officer/Principal | 01/01/2021 |
Anciens postes connus de Qinglei Zuo
| Sociétés | Poste | Fin |
|---|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | Sales & Marketing | 01/08/2018 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Corporate Officer/Principal | 01/03/2015 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | Corporate Officer/Principal | 01/09/2010 |
Formation de Qinglei Zuo
| Shanghai Institute of Pharmaceutical Industry | Graduate Degree |
| Yantai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUMENSION THERAPEUTICS | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Santen Pharmaceutical (China) Co. Ltd. | |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Eisai China, lnc. engages in the manufacture of pharmaceutical products. It offers medicines for digestive, endocrine, orthopedic, and cancer diseases. The company was founded on March 28, 1996 and is headquartered in Suzhou, China. | Health Technology |
| Shanghai Hengrui Pharmaceutical Co., Ltd. |
